BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:24 PM
 | 
Apr 30, 2008
 |  BC Extra  |  Clinical News

SkyePharma's Flutiform meets asthma endpoint

SkyePharma (LSE:SKP) said Flutiform fluticasone/formoterol met the primary endpoint of a significant improvement in FEV1 vs. formoterol and...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >